The aim of this new statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of ischemic stroke among survivors of ischemic stroke …

Objectives: The purpose of this study was to investigate the incidence, morphology, and
clinical course of thrombus formation after catheter closure of intra-atrial shunts …

Background The options for secondary prevention of cryptogenic embolism in patients with
patent foramen ovale are administration of antithrombotic medications or percutaneous …

Objective: To examine the association between patent foramen ovale (PFO) and atrial septal
aneurysm (ASA) and stroke. Method:—Data from case-control studies that examined the …

Background Patent foramen ovale and atrial septal aneurysm have been identified as
potential risk factors for stroke, but information about their effect on the risk of recurrent …

Background—Patent foramen ovale (PFO) is associated with stroke, but there are no
randomized studies to evaluate the efficacy of antithrombotic therapies. Methods and …

tion by TCD does not necessarily imply the presence of a PFO. Any right-to-left shunt such
as that resulting from ventricular septal defect or intrapulmonary shunt may result in the …

Patent Foramen Ovale: Current Pathology, Pathophysiology, and Clinical Status Hidehiko
Hara, Renu Virmani, Elena Ladich, Shannon MacKey-Bojack, Jack Titus, Mark Reisman …

Background—Patients with a patent foramen ovale (PFO) and paradoxical embolism are at
risk for recurrent thromboembolic events. This study investigated the long-term risk of …

Background: The optimal strategy to prevent recurrent presumed paradoxical emboli in
patients with patent foramen ovale is unknown. Purpose: To synthesize the current …